Thiamine supplementation in symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled, cross-over pilot study

Andreas W Schoenenberger, Renate Schoenenberger-Berzins, Christoph Auf der Maur, Paolo M Suter, Athanasios Vergopoulos, Paul Erne, Andreas W Schoenenberger, Renate Schoenenberger-Berzins, Christoph Auf der Maur, Paolo M Suter, Athanasios Vergopoulos, Paul Erne

Abstract

Background: Diuretic treatment for heart failure may lead to an increased urinary thiamine excretion and in long-term thiamine deficiency, which may further compromise cardiac function. This study evaluated the effect of high dose thiamine supplementation in heart failure patients.

Methods: Nine patients with diuretic treatment for symptomatic chronic heart failure and a left ventricular ejection fraction (LVEF) <40% were randomly assigned to receive thiamine (300 mg/day) or placebo for 28 days. After a wash-out of 6 weeks, the patients crossed-over to a second treatment period. The primary outcome was a change in LVEF.

Results: Mean age was 56.7 ± 9.2 years (range 44.9-75.4 years). Baseline LVEF was similar for both treatment groups (29.5% in the thiamine group and 29.5% in the placebo group, P = 0.911). After 28 days of thiamine treatment, the LVEF increased to 32.8% which was significantly (P = 0.024) different from the LVEF in the placebo group (28.8%). This corresponds to a treatment effect for LVEF of 3.9% in absolute terms.

Conclusions: This study suggests that thiamine supplementation has beneficial effects on cardiac function in patients with diuretic drugs for symptomatic chronic heart failure. Subclinical thiamine deficiency is probably an underestimated issue in these outpatients.

Trial registration: ClinicalTrials.gov NCT00770107.

References

    1. Eur J Heart Fail. 2009 Dec;11(12):1126-8
    1. Br J Clin Pharmacol. 1998 Oct;46(4):403-7
    1. Swiss Med Wkly. 2010 Apr 3;140(13-14):202-8
    1. Eur Heart J. 2005 Nov;26(21):2238-44
    1. Am J Cardiol. 2009 Jul 15;104(2):158-63
    1. Clin Res Cardiol. 2009 Apr;98(4):224-32
    1. J Am Geriatr Soc. 2008 Mar;56(3):510-6
    1. Am J Hypertens. 2010 Jul;23(7):775-80
    1. J Lab Clin Med. 1999 Sep;134(3):238-43
    1. J Am Coll Cardiol. 1989 May;13(6):1219-39
    1. Circ Heart Fail. 2010 Mar;3(2):294-305
    1. Am J Med. 1991 Aug;91(2):151-5
    1. J Nutr Health Aging. 2000;4(2):69-71
    1. J Am Coll Cardiol. 2006 Jan 17;47(2):354-61
    1. Cardiovasc Res. 1980 Sep;14(9):537-40
    1. Swiss Med Wkly. 2009 Aug 22;139(33-34):481-5
    1. Clin Res Cardiol. 2010 Apr;99(4):217-26
    1. Am J Med. 1995 May;98(5):485-90
    1. Nutr Rev. 2000 Oct;58(10):319-23
    1. Clin Res Cardiol. 2009 Oct;98(10):635-42
    1. Clin Res Cardiol. 2010 Feb;99(2):75-82
    1. Int J Vitam Nutr Res. 1994;64(2):113-8

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere